| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 7723 |
| 1 | PEMBROLIZUMAB | 5256 |
| 2 | ENZALUTAMIDE | 4780 |
| 3 | EVEROLIMUS | 3950 |
| 4 | CARBOPLATIN | 3442 |
| 5 | IPILIMUMAB | 2888 |
| 6 | CAPECITABINE | 2778 |
| 7 | LETROZOLE | 2656 |
| 8 | FULVESTRANT | 2483 |
| 9 | PACLITAXEL | 2384 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AFATINIB | 1487 | 0.2658 |
| 1 | GEFITINIB | 1517 | 0.1896 |
| 2 | CERITINIB | 380 | 0.1853 |
| 3 | PRALATREXATE | 82 | 0.1667 |
| 4 | OLAPARIB | 1221 | 0.1428 |
| 5 | PEMBROLIZUMAB | 5256 | 0.1422 |
| 6 | RAMUCIRUMAB | 594 | 0.1414 |
| 7 | FULVESTRANT | 2483 | 0.1282 |
| 8 | STREPTOZOCIN | 18 | 0.1277 |
| 9 | OSIMERTINIB | 1654 | 0.1271 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 13402 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13025 |
| 2 | Platinum-based Drug [EPC] | 5812 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 5349 |
| 4 | Androgen Receptor Inhibitor [EPC] | 5112 |
| 5 | Corticosteroid [EPC] | 5050 |
| 6 | Microtubule Inhibitor [EPC] | 4130 |
| 7 | Aromatase Inhibitor [EPC] | 4096 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 3997 |
| 9 | Alkylating Drug [EPC] | 3121 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 594 | 0.1414 |
| 1 | Estrogen Receptor Antagonist [EPC] | 2483 | 0.1282 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13025 | 0.1134 |
| 3 | Catecholamine Synthesis Inhibitor [EPC] | 4 | 0.1053 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 2888 | 0.1001 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1867 | 0.0873 |
| 6 | Androgen Receptor Inhibitor [EPC] | 5112 | 0.0867 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 615 | 0.0775 |
| 8 | Aromatase Inhibitor [EPC] | 4096 | 0.0535 |
| 9 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 213 | 0.0520 |